You are here

Pfizer lifts 2015 forecast despite fall in Q2 earnings

New York

PFIZER reported a dip in second-quarter profits on Tuesday, but boosted its forecast due in part to higher revenues from cancer drugs and global vaccines.

Earnings for the pharmaceutical giant for the quarter ending June 28 were US$2.6 billion, down 9.8 per cent from the